What is it about?
The SACVINFA study analysed the satisfaction with the health care received by patients, through the IEXPAC questionnaire, of a large cohort of patients with the most prevalent Immune-mediated inflammatory diseases (IMIDs) in Spain from the Pharmacy Service: inflammatory bowel disease, psoriasis, psoriatic arthritis, rheumatoid arthritis and spondyloarthropathies.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
The SACVINFA study is the first to evaluate the satisfaction in patients with the five most common IMIDs in Spain from the Pharmacy Service.
Read the Original
This page is a summary of: Evaluation of the hospital care quality perceived by patients with immune‐mediated inflammatory diseases from the pharmacy service.
SACVINFA
study, Journal of Clinical Pharmacy and Therapeutics, August 2022, Wiley,
DOI: 10.1111/jcpt.13742.
You can read the full text:
Contributors
The following have contributed to this page
